Haemonetics Goodwill and Intangible Assets 2010-2025 | HAE

Haemonetics goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Haemonetics Annual Goodwill and Intangible Assets
(Millions of US $)
2025 $1,060
2024 $971
2023 $742
2022 $778
2021 $832
2020 $344
2019 $339
2018 $368
2017 $388
2016 $472
2015 $579
2014 $608
2013 $595
2012 $212
2011 $217
2010 $210
2009 $122
Haemonetics Quarterly Goodwill and Intangible Assets
(Millions of US $)
2025-03-31 $1,060
2024-12-31 $1,071
2024-09-30 $1,104
2024-06-30 $1,108
2024-03-31 $971
2023-12-31 $984
2023-09-30 $716
2023-06-30 $734
2023-03-31 $742
2022-12-31 $750
2022-09-30 $758
2022-06-30 $769
2022-03-31 $778
2021-12-31 $792
2021-09-30 $806
2021-06-30 $820
2021-03-31 $832
2020-12-31 $335
2020-09-30 $342
2020-06-30 $355
2020-03-31 $344
2019-12-31 $318
2019-09-30 $325
2019-06-30 $331
2019-03-31 $339
2018-12-31 $345
2018-09-30 $352
2018-06-30 $360
2018-03-31 $368
2017-12-31 $375
2017-09-30 $381
2017-06-30 $384
2017-03-31 $388
2016-12-31 $453
2016-09-30 $461
2016-06-30 $467
2016-03-31 $472
2015-12-31 $482
2015-09-30 $571
2015-06-30 $576
2015-03-31 $579
2014-12-31 $586
2014-09-30 $594
2014-06-30 $602
2014-03-31 $608
2013-12-31 $612
2013-09-30 $619
2013-06-30 $621
2013-03-31 $595
2012-12-31 $595
2012-09-30 $620
2012-06-30 $210
2012-03-31 $212
2011-12-31 $212
2011-09-30 $214
2011-06-30 $217
2011-03-31 $217
2010-12-31 $211
2010-09-30 $207
2010-06-30 $202
2010-03-31 $210
2009-12-31 $146
2009-09-30 $147
2009-06-30 $137
2009-03-31 $122
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.545B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.799B 28.11
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.650B 26.61
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $13.236B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
GN Store Nord (GNNDY) Denmark $2.307B 19.11
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Surmodics (SRDX) United States $0.412B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanuwave Health (SNWV) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.29
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00